Enhanced TDS
Knowde-enriched technical product data sheet
Identification & Functionality
- Chemical Family
- Polymer Name
- Plastics & Elastomers Functions
- Technologies
- Product Families
Features & Benefits
Applications & Uses
- Plastics & Elastomers End Uses
- Plastics & Elastomers Processing Methods
- Applications
Drums and Industrial chemical containers up to 250 liter
- Processing Conditions
Typical processing conditions Blow Molding Extrusion Feed Zone (°C) 170 - 190 170 - 190 Zone 1 (°C) 180 - 200 180 - 200 Zone 2 (°C) 200 - 220 200 - 220 Zone 3 (°C) 200 - 220 200 - 220 Die (°C) 200 - 210 200 - 210 Melt Temp (°C) 200 - 220 200 - 220 - Safripol Medical Application Policy
Safripol will not knowingly sell or sample any product or service (“Product”) into any commercial or developmental application that is intended for:
a. permanent (Long term) contact with internal body fluids or internal body tissues. Long term is a use which exceeds 72 continuous hours.
b. use in cardiac prosthetic devices regardless of the length of time involved; (Cardiac prosthetic devices include, but are not limited to, pacemaker leads and devices, artificial hearts, heart valves, intra-aortic balloons and control systems, and ventricular bypass assisted devices);
c. use as a critical component in medical devices that support or sustain human life; or
d. use specifically by pregnant women or in applications designed specifically to promote or interfere with human reproduction.
Additionally, all Products intended for use in pharmaceutical applications, other than pharmaceutical packaging, must pass the current Pharmaceutical Liability Guidelines.
● New business opportunities require a business assessment prior to sale or sampling of Safripol products.
● Authorized distributors and resellers will adhere to this medical policy.
● Safripol does not endorse or claim suitability of their products for specific medical applications. It is the responsibility of the medical device or pharmaceutical manufacturer to determine that the Safripol product is safe, lawful, and technically suitable for the intended use.
SAFRIPOL MAKES NO WARRANTIES, EXPRESS OR IMPLIED, CONCERNING THE SUITABILITY OF ANY SAFRIPOL PRODUCT FOR USE IN MEDICAL APPLICATIONS.
Properties
- Mechanical Properties
Value Units Test Method / Conditions Hardness 63 Shore D ISO 868 Tensile Yield 26 MPa ISO 527 Ultimate Tensile 46 MPa ISO 527 Ultimate Elongation min. 600 % ISO 527 Flexural Modulus 1300 MPa ISO 178 Environmental Stress-Crack Resistance min. 1000 Hours ASTM D 1693 Charpy Notched Impact Strength (23 °C) 43 kJ/m2 ISO 179 Charpy Notched Impact Strength (-30 °C) 36 kJ/m2 ISO 179 - Physical Properties
Value Units Test Method / Conditions Melt Flow Rate (190 °C/ 5 kg) 0.2 g/10min ISO 1133 Melt Flow Rate (190 °C/ 2.16 kg) 5 g/10min ISO 1133 Density 0.953 g/cm3 ISO 1183 - Thermal Properties
Value Units Test Method / Conditions Vicat Softening Point A (10N) 129 °C ISO 306/A Vicat Softening Point B (50N) 80 °C ISO 306/B Crystalline Melting Range 130-133 °C ISO 3146
Regulatory & Compliance
- Certifications & Compliance
- Food Contact Compliance
Safrene® M 6650 High Density Polyethylene Resin should comply with Commission Regulation (EU) No 10/2011 and with U.S. FDA 21 CFR 177.1520(c)3.2a food contact regulations when used unmodified and processed according to good manufacturing practices for food contact applications. The purchaser remains responsible for determining whether the use complies with all relevant regulations.